Research Frontiers, Inc. (NASDAQ:REFR)
About the company
Research Frontiers, Inc. engages in development, licensing and commercialization of suspended particle device (SPD) light-control technology for automobiles, homes, buildings, aircraft, boats, exhibition and display applications markets. It develops and licenses technologies to other companies that manufactures and markets SPD-smart chemical emulsion or light-control film made from chemical emulsion, lamination services and electronics to power end-products incorporating the film, skylights and sunroofs. The company was founded by Robert L. Saxe in October 1965 and is headquartered in Woodbury, NY.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|Lam Research Corp.||LRCX||48878.70||9614.00||10.33||23.30||21.81|
|Brooks Automation, Inc.||BRKS||3245.58||834.00||2.82||7.30||52.98|
|Advanced Energy Industries, Inc.||AEIS||2622.36||964.00||3.75||38.20||7.02|
|Vertiv Holdings Co.||VRT||1758.75||897.00||13.93||-12.79||-29.78|
|Nova Measuring Instruments Ltd.||NVMI||1410.85||229.00||4.17||35.51||17.05|
|Onto Innovation, Inc.||ONTO||1227.96||385.00||1.35||-103.36||-2.62|
|Electro Scientific Industries, Inc.||ESIO||1079.64||378.00||3.18||8.31||34.25|
|Axcelis Technologies, Inc.||ACLS||931.26||370.00||2.11||42.14||5.99|
|Veeco Instruments, Inc.||VECO||643.20||424.00||1.76||-10.55||-14.32|
|Research Frontiers, Inc.||REFR||119.66||2.00||19.30||-32.17||-241.73|
|SGOCO Group Ltd.||SGOC||90.85||6.00||0.92||-4.79||-351.17|
|Richardson Electronics Ltd.||RELL||53.04||161.00||0.44||-7.56||-4.32|
|Aehr Test Systems||AEHR||43.24||26.00||2.61||188.00||0.75|
|CVD Equipment Corp.||CVV||20.51||22.00||0.61||-7.71||-11.22|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
Research Frontiers (Nasdaq: REFR) today announced that it has been added to the Russell 2000® Index effective at the U.S. market open today, June 29, 2020. The Annual Russell index reconstitution ...
MediciNova Announces Positive Preclinical Results Regarding MN-166 (ibudilast) in Glioblastoma (GBM) Published in Frontiers in Immunology
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced positive ...
Exxon is moving to rapidly expand its exploration footprint in this little-known venue, French Total SA is spudding its first ...
Frontier Scientific identified and developed multiple synthetic processes to produce stannous protoporphyrin (SnPP) – the ...
Jefferies Financial Group Research Analysts Cut Earnings Estimates for HollyFrontier Corp (NYSE:HFC)
Analysts at Jefferies Financial Group lowered their FY2022 earnings estimates for HollyFrontier in a research report issued ...
Frontier Scientific Develops and Provides Process to Produce Active Pharmaceutical Ingredient for Clinical Trial of COVID-19 Therapeutic Investigational Drug RBT-9
Frontier Scientific Inc. develops process for Covid-19 active pharmaceutical ingredient for Renibus clinical trial of Covid-19 therapeutic.
The Ohio Third Frontier Commission has awarded $2.4 million to two Northeast Ohio universities and eight companies to help ...